Abstract
Caeruloplasmin has been determined immunologically and by coper oxidase activity in 25 normal subjects, 20 patients with Wilson's disease, and 80 patients with chronic liver disease. Repeated estimation in four patients with Wilson's disease and two heterozygous mothers from two families revealed a consistent reduction in the copper oxidase activity of caeruloplasmin (12-32 units copper oxidase activity/mg caeruloplasmin) relative to the values obtained in normal subjects, patients with chronic liver disease, and other Wilson's disease patients (mean 65-79 units/mg). It is suggested that the functional abnormality in caeruloplasmin observed in these two families is an inherited variant, which does not appear to be due to the presence of a serum inhibitor of copper oxidase.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BEARN A. G. Genetic and biochemical aspects of Wilson's disease. Am J Med. 1953 Oct;15(4):442–449. doi: 10.1016/0002-9343(53)90134-x. [DOI] [PubMed] [Google Scholar]
- BICKEL H., NEALE F. C., HALL G. A clinical and biochemical study of hepatolenticular degeneration (Wilson's disease). Q J Med. 1957 Oct;26(104):527–558. [PubMed] [Google Scholar]
- CURZON G., VALLET L. The purification of human caeruloplasmin. Biochem J. 1960 Feb;74:279–287. doi: 10.1042/bj0740279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cox D. W., Fraser F. C., Sass-Kortsak A. A genetic study of Wilson's disease: evidence for heterogeneity. Am J Hum Genet. 1972 Nov;24(6 Pt 1):646–666. [PMC free article] [PubMed] [Google Scholar]
- MORELL A. G., SCHEINBERG I. H. Heterogeneity of human ceruloplasmin. Science. 1960 Mar 25;131(3404):930–932. doi: 10.1126/science.131.3404.930. [DOI] [PubMed] [Google Scholar]
- SCHEINBERG I. H., GITLIN D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science. 1952 Oct 31;116(3018):484–485. doi: 10.1126/science.116.3018.484. [DOI] [PubMed] [Google Scholar]
- SCHEINBERG I. H., STERNLIEB I. Wilson's disease and the concentration of caeruloplasmin in serum. Lancet. 1963 Jun 29;1(7296):1420–1421. doi: 10.1016/s0140-6736(63)92070-1. [DOI] [PubMed] [Google Scholar]
- Sternlieb I., Scheinberg I. H. Prevention of Wilson's disease in asymptomatic patients. N Engl J Med. 1968 Feb 15;278(7):352–359. doi: 10.1056/NEJM196802152780702. [DOI] [PubMed] [Google Scholar]
- Sternlier I., Morell A. G., Bauer C. D., Combes B., De Bobes-Sternberg S., Schein-Berg I. H. DETECTION OF THE HETEROZYGOUS CARRIER OF THE WILSON'S DISEASE GENE. J Clin Invest. 1961 Apr;40(4):707–715. doi: 10.1172/JCI104304. [DOI] [PMC free article] [PubMed] [Google Scholar]